Amarin Corp Plc (AMRN)

[Biobillionair]

Thanks for your opinion and insight; please take the time to contribute your thoughts Re: Vascepa and sales after top line R-I results. For example, if "V" only shows a paltry Vytorin RRR ~7% vs. a Crestor RRR ~ 40%?

Considering the safety profile I think sales still reach $1 billion per year with ~7% RRR due to safety & value.

If "V" hits a JUPITOR homer (like I expect), "V" sells >> $10 billion per year just in US.

Your thoughts?

BB